Prognostic value of tissue polypeptide antigen in oral squamous cell carcinoma

Oral Oncology

Volumn 47, Issue 2, 2011, Pages 114-120

  Sawant, Sharada S ^a   Chaukar, Devendra A ^a   Joshi, Shreyas S ^a   Dange, Prerana P ^a   Kannan, Sadhana ^a   Kane, Shubhada ^a   D'Cruz, Anil K ^a   Vaidya, Milind M ^a  

^a TATA MEMORIAL HOSPITAL   (India)

Author keywords

Cytokeratins; Oral cancer; Prognosis; Serum tumour markers; Squamous cell carcinoma; Tissue polypeptide antigen

Indexed keywords

CYTOKERATIN 18; CYTOKERATIN 19; CYTOKERATIN 8; TISSUE POLYPEPTIDE ANTIGEN; TUMOR MARKER;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNORADIOMETRIC ASSAY; MAJOR CLINICAL STUDY; MALE; MOUTH CARCINOMA; MOUTH SQUAMOUS CELL CARCINOMA; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA;

ADULT; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; IMMUNORADIOMETRIC ASSAY; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; TISSUE POLYPEPTIDE ANTIGEN; TUMOR MARKERS, BIOLOGICAL;

EID: 79551682472     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2010.11.005     Document Type: Article

References (57)

1. G. Lodi, A. Sardella, C. Bez, F. Demarosi, and A. Carrassi Interventions for treating leukoplakia Cochrane Database Syst Rev 3 2004 CD001829
2. Nandkumar A. Consolidated report of the population based cancer registries 1990-1996. Incidence and distribution of cancer. New Delhi: National Cancer Registry Programme by ICMR; 1996.
3. S.P. Schantz Carcinogenesis, markers, staging and prognosis of head and neck cancer Curr Opin Oncol 5 1993 483 490
4. L.G. Close Computed tomography evaluation of regional lymph node involvement in cancer of the oral cavity and oropharynx Otolaryngol Head Neck Surg 11 1989 309 317
5. W.B. Stern, C.E. Silver, B.A. Zeifer, M.S. Persky, and K.S. Heller Computed tomography of the clinically negative neck Head Neck 12 2 1990 109 113
6. M.W.M. Brekel Magnetic resonance imaging vs palpation of cervical lymph node metastases Arch Otolaryngol Head Neck Surg 117 1991 666 673
7. Sharada S. Sawant, Surekha M Zingde, and Milind M. Vaidya Cytokeratin fragments in the serum: Their utility for the management of oral cancer Review: Oral Oncology 44 2008 722 732
8. V. Barak, H. Goike, K.W. Panaretakis, and R. Einarsson Clinical utility of cytokeratins as tumor markers Clin Biochem 37 7 2004 529 540
9. C.J. Menendez-Botet, H.F. Oettgen, C.M. Pinsky, and M.K. Schwartz A preliminary evaluation of tissue polypeptide antigen in serum or urine (or both) of patients with cancer or benign neoplasms Clin Chem 24 1978 868 872
10. B. Calsen, P. Pere, R. Senekowitsch, and E. Menz SCC as a tumour marker in the initial diagnosis of carcinoma of the head and neck region Laryngorhinootologie 65 1990 275 280
11. C.F. Chou, A.J. Smith, and M.B. Omary Characterization and dynamics of O-linked glycosylation of human cytokeratin 8 and 18 J Biol Chem 267 6 1992 3901 3906
12. M.B. Omary, N.O. Ku, J. Liao, and D. Price Keratin modifications and solubility properties in epithelial cells and in vitro Subcell Biochem 31 1998 105 140
13. M.M. Vaidya, A.M. Borges, S.A. Pradhan, R.M. Rajpal, and A.N. Bhisey Altered keratin expression in buccal mucosal squamous cell carcinoma J Oral Pathol Med 18 5 1989 282 286
14. M.M. Vaidya, A.M. Borges, S.A. Pradhan, and A.N. Bhisey Cytokeratin expression in squamous cell carcinomas of the tongue and alveolar mucosa Eur J Cancer B Oral Oncol 32B 5 1996 333 336
15. F. Thomas, W. Richard, P. Jens, B. Burkhard, M. Philippe, and W. Dieter BMC Cancer 6 2006 10
16. K. Ranganathan, R. Kavitha, S.S. Sawant, and M.M. Vaidya Cytokeratin expression in oral submucous fibrosis-an immunohistochemical study J Oral Pathol Med 35 1 2006 25 32
17. U.B. Raul, S.S. Sawant, P.P. Dange, R.D. Kalraiya, and M.M. Vaidya Implications of CK8 and 18 filament formation in stratified epithelial cells: induction of transformed phenotype Int J Cancer 111 5 2004 662 668
18. Y. Yoshimura, M. Oka, and T. Harada Squamous cell carcinoma-antigen for detection of squamous cell and mucoepidermoid carcinoma after primary treatment: a preliminary report J Oral Maxillofac Surg 48 12 1990 1288 1292 discussion 1292-83
19. N.A. Silverman, J.C. Alexander, and P.B. Chretien CEA levels in head and neck cancer Cancer 37 5 1976 2204 2211
20. N. Katopodis, Y. Hirshaut, N.L. Geller, and C.C. Stock Lipid-associated sialic acid test for the detection of human cancer Cancer Res 42 12 1982 5270 5275
21. E.K. Walther, N. Dahlmann, and H.T. Gorgulla Tumor markers in patients with head-neck carcinomas Laryngorhinootologie 69 5 1990 271 274
22. M.E. Ropka, W.J. Goodwin, P.A. Levine, C.T. Sasaki, J.C. Kirchner, and R.W. Cantrell Effective head and neck tumor markers. The continuing quest Arch Otolaryngol Head Neck Surg 117 9 1991 1011 1014
23. B. Wollenberg, N. Jan, W. Sautier, K. Hofmann, U.M. Schmitt, and P. Stieber Serum levels of intercellular adhesion molecule-1 in squamous cell carcinoma of the head and neck Tumour Biol 18 2 1997 88 94
24. D. Ayude, G. Gacio, M. Paez de la Cadena, E. Pallas, V.S. Martinez-Zorzano, and A. de Carlos Combined use of established and novel tumour markers in the diagnosis of head and neck squamous cell carcinoma Oncol Rep 10 5 2003 1345 1350
25. R.M. Nagler, M. Barak, M. Peled, H. Ben-Aryeh, M. Filatov, and D. Laufer Early diagnosis and treatment monitoring roles of tumor markers Cyfra 21-1 and TPS in oral squamous cell carcinoma Cancer 85 5 1999 1018 1025
26. D.M. Mellerick, M. Osborn, and K. Weber On the nature of serological tissue polypeptide antigen (TPA); monoclonal keratin 8, 18 and 19 antibodies react differently with TPA prepared from human cultured carcinoma cells and TPA in human serum Oncogene 5 1990 1007 1017
27. F. Smedts, F. Ramaekers, S. Troyanovsky, M. Pruszczynski, M. Link, and B. Lane Keratin expression in cervical cancer Am J Pathol 141 2 1992 497 511
28. R. Moll, W.W. Franke, D.L. Schiller, B. Geiger, and R. Krepler The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells Cell 31 1 1982 11 24
29. C.A. Makin, and L.G. Bobrow W.F. B. Monoclonal antibody to cytokeratin for use in routine histopathology J Clin Path 37 1984 975 983
30. J.L. Broers, F.C. Ramaekers, M.K. Rot, T. Oostendorp, A. Huysmans, and G.N. van Muijen Cytokeratins in different types of human lung cancer as monitored by chain-specific monoclonal antibodies Cancer Res 48 11 1988 3221 3229
31. R.B. Presland, and R. Jurevic Making sense of the epithelial barrier what molecular biology and genetics tell us about the functions of oral mucosal and epidermal and epidermal tissues J Dent Educ 66 4 2002 564 574
32. C.A. Makin, L.G. Bobrow, and W.F. Bodmer Monoclonal antibody to cytokeratin for use in routine histopathology J Clin Path 37 1984 975 983
33. K. Lindberg, and J.G. Rheinwald Suprabasal 40 kd keratin (K19) expression as an immunohistologic marker of premalignancy in oral epithelium Am J Pathol 134 1 1989 89 98
34. F. Ramaekers, A. Huijsmans, and O. Moesker Monoclonal antibody to keratin filaments, specific for glandular epithelia and their tumours: use in surgical pathology Lab Invest 49 1983 353 361
35. U. Raul, S. Sawant, P. Dange, R. Kalraiya, A. Ingle, and M. Vaidya Implications of cytokeratin 8/18 filament formation in stratified epithelial cells: induction of transformed phenotype Int J Cancer 111 5 2004 662 668
36. H. Bodenmuller, B. Ofenloch-Hahnle, E.B. Lane, A. Dessauer, V. Bottger, and F. Donie Lung cancer-associated keratin 19 fragments: development and biochemical characterisation of the new serum assay Enzymun-Test CYFRA 21-1 Int J Biol Markers 9 2 1994 75 81
37. R. Molina, M.D. Torres, M. Moragas, X. Filella, J. Jo, and N. Gimenez Prognostic value of TPS in patients with head and neck malignancies: comparison with SCC Anticancer Res 15 2 1995 479 484
38. A. Banal, K. Hacene, E. Berthelot-Ruff, E. Mahe, X. Fontana, and M.F. Pichon Comparison of Cyfra 21-1 and SCC assays in head and neck tumours Tumour Biol 22 1 2001 27 35
39. R. Molina, M.D. Torres, M. Moragas, J. Perez-Villa, X. Filella, and J. Jo Prognostic significance of SCC antigen in the serum of patients with head and neck cancer Tumour Biol 17 2 1996 81 89
40. L. Sanislo, and J. Kausitz Predictive value of cytokeratin 18 fragments in patients with locally advanced head and neck tumours Tumor Biol 24 2003 80
41. G. Buccheri, and D. Ferrigno Prognostic value of the tissue polypeptide antigen in lung cancer Chest 101 5 1992 1287 1292
42. V. Barak, B. Nisman, I. Roisman, A. Hubert, and T. Peretz Clinical utility of TPS in breast cancer Tumor Biol 59 1998
43. A. Gadducci, M. Ferdeghini, S. Cosio, A. Fanucchi, R. Cristofani, and A.R. Genazzani The clinical relevance of serum CYFRA 21-1 assay in patients with ovarian cancer Int J Gynecol Cancer 11 4 2001 277 282
44. I. Doweck, M. Barak, N. Uri, and E. Greenberg The prognostic value of the tumour marker Cyfra 21-1 in carcinoma of head and neck and its role in early detection of recurrent disease Br J Cancer 83 12 2000 1696 1701
45. A. Hoffmann-Fazel, M. Hoffmann, S. Gottschlich, J.D. Maass, H. Rudert, and S. Maune Cyfra 21-1 in diagnosis of distant metastases of head and neck carcinoma Anticancer Res 23 2A 2003 917 920
46. G. Buccheri, and D. Ferrigno Usefulness of tissue polypeptide antigen in staging, monitoring, and prognosis of lung cancer Chest 93 3 1988 565 570
47. O.P. Khanna, and B. Wu Tissue polypeptide antigen (TPA) as a predictor for genitourinary cancers and their metastases Urology 30 2 1987 06 110
48. C. Maulard-Durdux, M.E. Toubert, C. Hennequin, and M. Housset Serum tissue polypeptide antigen in bladder cancer as a tumor marker: a prospective study J Clin Oncol 15 12 1997 3446 3450
49. Thorsten.H. Ecke, Horst.H. Schlechte, Guntram. Schulze, Severin.V. Lenk, and S.A. Loening Four Tumour Markers for Urinary Bladder Cancer - Tissue Polypeptide Antigen (TPA), HER-2/neu (ERB B2), Urokinase-type Plasminogen Activator Receptor (uPAR) and TP53 Mutation Jpn J Clin Oncol 30 2000 215 220
50. G. Soletormos, D. Nielsen, V. Schioler, T. Skovsgaard, and P. Dombernowsky Tumor markers cancer antigen 15.3, carcinoembryonic antigen, and tissue polypeptide antigen for monitoring metastatic breast cancer during first-line chemotherapy and follow-up Clin Chem 42 1996 564 575
51. I. Doweck, M. Barak, E. Greenberg, N. Uri, J. Kellner, and M. Lurie Cyfra 21-1. A new potential tumor marker for squamous cell carcinoma of head and neck Arch Otolaryngol Head Neck Surg 121 2 1995 177 181
52. W. Ebert, H. Dienemann, A. Fateh-Moghadam, M. Scheulen, N. Konietzko, and T. Schleich Cytokeratin 19 fragment CYFRA 21-1 compared with carcinoembryonic antigen, squamous cell carcinoma antigen and neuron-specific enolase in lung cancer. Results of an international multicentre study Eur J Clin Chem Clin Biochem 32 3 1994 189 199 (Pubitemid 24096845)
53. van der Gaast A, Schoenmakers CH, Kok TC, Blijenberg BG, Cornillie F, Splinter TA. Evaluation of a new tumour marker in patients with non-small-cell lung cancer: Cyfra 21.1. Br J Cancer 1994;69(3):525-28.
54. Y.F. Deng, P. Chen, Y.Z. Lin, J.Z. Le, X.L. Wu, and M.Q. Yu Analytical and clinical evaluation of CYFRA 21-1 by electrochemiluminescent immunoassay in head and neck squamous cell carcinoma J Laryngol Otol 117 3 2003 190 194
55. A.C. Brabon, J.F. Williams, and R.D. Cardiff A monoclonal antibody to a human breast tumor protein released in response to estrogen Cancer Res Jun 44 6 1984 2704 2710
56. N.O. Ku, J. Liao, and M.B. Omary Apoptosis generates stable fragments of human type I keratins J Biol Chem 272 52 1997 33197 33203
57. G. Kramer, H. Erdal, H.J. Mertens, M. Nap, J. Mauermann, and G. Steiner Differentiation between cell death modes using measurements of different soluble forms of extracellular cytokeratin 18 Cancer Res 64 5 2004 1751 1756